1.
Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patierns with type 2 diabetes, hypertension, and renal disease in Switzerland. Swiss Med Wkly [Internet]. 2006 May 27 [cited 2026 Apr. 2];136(2122):346-. Available from:
https://smw.ch/index.php/smw/article/view/611